BCM
IMMU

Bienville Capital Management’s Immunomedics Inc IMMU Stock Holding History

Bienville Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,000
Closed -$48K – 97
2014
Q4 		$48K Buy
+10,000
New +$39.5K 0.04% 101

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bienville Capital Management's IMMU Position: Q1 2015 in Review

Bienville Capital Management sold out of Immunomedics Inc (IMMU) in Q1 2015, closing a stake of 10,000 shares — an estimated $48K sold.

Bienville Capital Management first reported a position in IMMU in Q4 2014 and held it in 1 quarter. The position peaked at $48K in Q4 2014. 86 funds tracked by Wall St. Rank hold IMMU as of Q1 2015.

  • Bienville Capital Management reported no remaining Immunomedics Inc position as of Q1 2015 after selling out during the quarter.
  • Bienville Capital Management sold 10,000 Immunomedics Inc shares in Q1 2015, an estimated $48K.
  • Bienville Capital Management first reported a position in Immunomedics Inc in Q4 2014 and held it in 1 quarter.
  • Bienville Capital Management's Immunomedics Inc position peaked at $48K in Q4 2014.
  • 86 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2015.

Based on Bienville Capital Management's 13F filing for Q1 2015, filed 13 May 2015.